A synthetic benzoxazine dimer derivative targets c-Myc to inhibit colorectal cancer progression.
Saved in:
| Title: | A synthetic benzoxazine dimer derivative targets c-Myc to inhibit colorectal cancer progression. |
|---|---|
| Authors: | Sriratanasak N; Faculty of Pharmaceutical Sciences, Department of Pharmacology and Physiology, Chulalongkorn University, Bangkok, Thailand.; Faculty of Pharmaceutical Sciences, Center of Excellence in Cancer Cell and Molecular Biology, Chulalongkorn University, Bangkok, Thailand.; Experimental Tumorpathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany.; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany., Nutho B; Faculty of Science, Department of Pharmacology, Mahidol University, Bangkok, Thailand., Wattanathana W; Faculty of Engineering, Department of Materials Engineering, Kasetsart University, Bangkok, Thailand., Phaonakrop N; Functional Proteomics Technology Laboratory, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathumthani, Thailand, 12120., Panasawatwong B; Faculty of Science, Department of Pharmacology, Mahidol University, Bangkok, Thailand., Erlenbach-Wuensch K; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany., Roytrakul S; Functional Proteomics Technology Laboratory, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathumthani, Thailand, 12120., Schneider-Stock R; Experimental Tumorpathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany.; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Germany.; Adjunct professor at Mahidol University, Bangkok, Thailand., Chanvorachote P; Faculty of Pharmaceutical Sciences, Department of Pharmacology and Physiology, Chulalongkorn University, Bangkok, Thailand.; Faculty of Pharmaceutical Sciences, Center of Excellence in Cancer Cell and Molecular Biology, Chulalongkorn University, Bangkok, Thailand.; Sustainable Environment Research Institute, Chulalongkorn University, Bangkok, Thailand. |
| Source: | Molecular oncology [Mol Oncol] 2026 Mar; Vol. 20 (3), pp. 688-708. Date of Electronic Publication: 2025 Oct 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1878-0261 |
|---|---|
| DOI: | 10.1002/1878-0261.70127 |
